Pro Bono Bio is a leading nano-lipid, healthcare technology company focusing on pain, haematology and dermatology. Over the past few years, Pro Bono Bio has launched the FLEXISEQ and SEQuaderma ranges.

Pro Bono Bio wanted to upgrade its annual 2015 Financial Report from a plain word document to a glossy, well-designed publication. The published version needed to be produced quickly and to a tight budget.

Once given the raw document, the Richmond Marketing Consultancy was able to quickly produce an eye catching, professional looking ninety page Financial Report within the client deadlines.